Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Sep 2023
Consolidate Net Profit
YoY Growth in quarter ended Sep 2024 is 7.69% vs -77.27% in Sep 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2024 is 7.69% vs -116.67% in Sep 2023
Interest
YoY Growth in quarter ended Sep 2024 is 300.00% vs 0.00% in Sep 2023
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2024 has improved from Sep 2023
Compare Quarterly Results Of Panbela Therapeutics, Inc. With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2024 is -1.41% vs 0.00% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 7.69% vs -77.27% in Sep 2023
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2024 is 11.11% vs -20.90% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 7.69% vs -116.67% in Sep 2023
Quarterly - Interest
QoQ Growth in quarter ended Sep 2024 is 300.00% vs 0.00% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 300.00% vs 0.00% in Sep 2023






